Save time and get answers to complex questions with AI chat
Testosterone enanthate expiration?Patent expiration eu dabrafenib?Are there income restrictions for lipitor's patient program?Generic brand for latisse?Drugpatentwatch skyrizi biologic patent analysis?
See the DrugPatentWatch profile for Neupogen
Neupogen (filgrastim) was approved by the FDA on February 20, 1991. [1]
This refers to the original FDA approval date for the drug product (filgrastim) as a manufacturing/label-approved therapy. [1]
Neupogen is the brand name for filgrastim, and it has had multiple later formulations and biosimilar competition in the filgrastim market, but the original FDA brand approval date remains February 20, 1991. [1]
Other Questions About Neupogen :